Concepedia

Hala Elnakat Thomas

HE

Statistics

Publications

9

Citations

610

H-Index

9

Active since

2012

Affiliations

University of Cincinnati(Current)

University of Cincinnati Medical Center

Institut d'Investigació Biomédica de Bellvitge

Bellvitge University Hospital

University of Wisconsin–Madison

Hala Elnakat Thomas is an author at University of Cincinnati specializing in oncology, pharmacology, and mtor signaling.

Publications per year

2012–2020

9

Publications

9

Mitochondrial Complex I Activity Is Required for Maximal Autophagy

Hala Elnakat Thomas, Yu Zhang, Jonathan A. Stefely et al. · Cell Reports · 2018 · 130 citations · Full text

, , +17

A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

Trisha M. Wise‐Draper, Ganesh Moorthy, Mohamad A. Salkeni et al. · Targeted Oncology · 2017 · 115 citations · Full text

, , +17

Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serum

Scott M. Langevin, Damaris Kuhnell, Melissa A. Orr–Asman et al. · RNA Biology · 2019 · 96 citations · Full text

, , +17

mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma

Hala Elnakat Thomas, Carol A. Mercer, Larissa S. Carnevalli et al. · Science Translational Medicine · 2012 · 92 citations

, , +17

Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagy

Jonathan A. Stefely, Yu Zhang, Elyse C. Freiberger et al. · Autophagy · 2020 · 57 citations · Full text

, , +17

1–5 of 9